Radical Numerics, a San Francisco-based startup, has raised $50 million in seed funding to develop AI models for biology and biosecurity. The company aims to accelerate drug discovery and defend against AI-generated biological threats.
TL;DR
- Radical Numerics raises $50M to build AI models for biology and biosecurity.
- The company aims to accelerate drug discovery and defend against AI-generated threats.
- Investors are pouring money into startups focusing on both scientific discovery and biodefense.
What happened
Radical Numerics emerged from stealth with a $50 million seed round led by Emergence Capital, with participation from Obvious Ventures, Triatomic Capital, Factory, and First Spark Ventures. The startup also received pre-seed backing from Stripe co-founder Patrick Collison.
The company was founded by the team behind Evo, one of the first AI models capable of reading and generating DNA sequences at scale. Radical Numerics aims to build 'general biological intelligence,' or multimodal AI models that can reason across DNA, RNA, proteins, and other biological data.
Alongside the funding, the company previewed Omnii, its next-generation genome language model. The company's dual focus on human health and biodefense reflects a growing theme in frontier AI investing.
Why it matters
Radical Numerics' technology has the potential to accelerate drug discovery, cancer diagnostics, and biosecurity. The company's AI models could help detect and defend against AI-generated biological threats, a growing concern in the AI community.
The investment in Radical Numerics is part of a broader trend of investors pouring money into startups focusing on both scientific discovery and biodefense. As AI models become increasingly capable of designing biological systems, the need for biodefense solutions is also growing.
However, the development of AI models for biology also raises ethical concerns. Radical Numerics CEO Eric Nguyen acknowledged the responsibility that comes with developing such powerful technology, stating that the same models that can help cure disease may also lower the barrier to designing harmful biology.
Key facts
- Radical Numerics raises $50M in seed funding.
- Emergence Capital leads the round, with participation from Obvious Ventures, Triatomic Capital, Factory, and First Spark Ventures.
- Stripe co-founder Patrick Collison provides pre-seed backing.
- The company aims to build 'general biological intelligence' for drug discovery, cancer diagnostics, and biosecurity.
- Radical Numerics previews Omnii, its next-generation genome language model.
- The company's dual focus on human health and biodefense reflects a growing theme in frontier AI investing.
- Crunchbase data shows tens of millions of dollars have been poured into startups promising to accelerate scientific discovery and help detect and defend against AI-generated biological threats.
Context
The AI gold rush has reached various industries, from home services to defense and financial services. Startups like Probook, Traysar, Pie, and Nomerra are leveraging AI to streamline operations, improve efficiency, and drive growth in their respective sectors.
Probook, a New York-based startup, raised $40 million to build an AI operating system for home service businesses. The company aims to replace the patchwork of software many contractors use with a single platform centered on dispatch.
Traysar, an Austin-based startup, raised $25 million to develop autonomous platforms for subterranean warfare. The company's technology could give military operators a way to explore or disable underground networks without sending in troops.